Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-09-05
2006-09-05
Weber, Jon (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S021800, C514S832000, C514S833000, C530S385000, C530S402000, C530S813000, C530S815000, C530S829000, C424S529000
Reexamination Certificate
active
07101846
ABSTRACT:
Compositions, and methods of use thereof, for use as blood substitute products comprise aqueous mixtures of oxygen-carrying and non-oxygen carrying plasma expanders and methods for the use thereof. The oxygen-carrying component may consist of any hemoglobin-based oxygen carrier, while the non-oxygen carrying plasma expander my consist of any suitable diluent.
REFERENCES:
patent: 3925344 (1975-12-01), Mazur
patent: 3956259 (1976-05-01), Garcia et al.
patent: 4001200 (1977-01-01), Bonsen et al.
patent: 4001401 (1977-01-01), Bonsen et al.
patent: 4053590 (1977-10-01), Bonsen et al.
patent: 4061736 (1977-12-01), Morris et al.
patent: 4064118 (1977-12-01), Wong
patent: 4113853 (1978-09-01), Funakoshi et al.
patent: 4133874 (1979-01-01), Miller et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4316093 (1982-02-01), Broers et al.
patent: 4336248 (1982-06-01), Bonhard et al.
patent: 4377512 (1983-03-01), Ajisaka et al.
patent: 4401652 (1983-08-01), Simmonds et al.
patent: 4412989 (1983-11-01), Iwashita et al.
patent: 4439357 (1984-03-01), Bonhard et al.
patent: 4473494 (1984-09-01), Tye
patent: 4473496 (1984-09-01), Scannon
patent: 4526715 (1985-07-01), Kothe et al.
patent: 4529719 (1985-07-01), Tye
patent: 4532130 (1985-07-01), Djordjevich et al.
patent: 4584130 (1986-04-01), Bucci et al.
patent: 4598064 (1986-07-01), Walder
patent: 4600531 (1986-07-01), Walder
patent: 4650786 (1987-03-01), Wong
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4710488 (1987-12-01), Wong
patent: 4730936 (1988-03-01), Thorjusen, Jr.
patent: 4738952 (1988-04-01), Ecanow et al.
patent: 4777244 (1988-10-01), Bonhard et al.
patent: 4826811 (1989-05-01), Sehgal et al.
patent: 4831012 (1989-05-01), Estep
patent: 4857636 (1989-08-01), Hsia
patent: 4861867 (1989-08-01), Estep
patent: 4900780 (1990-02-01), Cerny
patent: 4911929 (1990-03-01), Farmer et al.
patent: 4920194 (1990-04-01), Feller et al.
patent: 4987154 (1991-01-01), Long, Jr.
patent: 5028588 (1991-07-01), Hoffman et al.
patent: 5041615 (1991-08-01), Hai et al.
patent: 5061688 (1991-10-01), Beissinger et al.
patent: 5077036 (1991-12-01), Long, Jr.
patent: 5080885 (1992-01-01), Long, Jr.
patent: 5084558 (1992-01-01), Rausch et al.
patent: 5114932 (1992-05-01), Runge
patent: 5115100 (1992-05-01), Wu et al.
patent: 5128452 (1992-07-01), Hai et al.
patent: 5194590 (1993-03-01), Sehgal et al.
patent: 5200323 (1993-04-01), Chang et al.
patent: 5217648 (1993-06-01), Beissinger et al.
patent: 5234903 (1993-08-01), Nho et al.
patent: 5239061 (1993-08-01), Fronticelli et al.
patent: 5248766 (1993-09-01), Nelson et al.
patent: 5250665 (1993-10-01), Kluger et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5264555 (1993-11-01), Shorr et al.
patent: 5281579 (1994-01-01), Estep
patent: 5295944 (1994-03-01), Teicher et al.
patent: 5296465 (1994-03-01), Rausch et al.
patent: 5312808 (1994-05-01), Shorr et al.
patent: 5334705 (1994-08-01), Bonaventura et al.
patent: 5334706 (1994-08-01), Przybelski
patent: 5344393 (1994-09-01), Roth et al.
patent: 5349054 (1994-09-01), Bonaventura et al.
patent: 5352773 (1994-10-01), Kandler et al.
patent: 5386014 (1995-01-01), Nho et al.
patent: 5407428 (1995-04-01), Segall et al.
patent: 5438041 (1995-08-01), Zheng et al.
patent: 5439591 (1995-08-01), Pliura et al.
patent: 5449759 (1995-09-01), Hoffman et al.
patent: 5451205 (1995-09-01), Roth et al.
patent: 5464814 (1995-11-01), Sehgal et al.
patent: 5478805 (1995-12-01), Shorr et al.
patent: 5478806 (1995-12-01), Nho
patent: 5480866 (1996-01-01), Bonaventura et al.
patent: 5510464 (1996-04-01), Przybelski
patent: 5525630 (1996-06-01), Hoffman
patent: 5532352 (1996-07-01), Pliura et al.
patent: 5545328 (1996-08-01), Pliura et al.
patent: 5545727 (1996-08-01), Hoffman et al.
patent: 5554638 (1996-09-01), Dewhirst et al.
patent: 5563254 (1996-10-01), Hoffman et al.
patent: 5571801 (1996-11-01), Segall et al.
patent: 5574019 (1996-11-01), Segall et al.
patent: 5578564 (1996-11-01), Chivers et al.
patent: 5585484 (1996-12-01), Acharya et al.
patent: 5591710 (1997-01-01), Hsia
patent: 5595723 (1997-01-01), Quay
patent: 5599907 (1997-02-01), Anderson et al.
patent: 5613944 (1997-03-01), Segall et al.
patent: 5614490 (1997-03-01), Przybelski
patent: 5618919 (1997-04-01), Rausch et al.
patent: 5628930 (1997-05-01), Weers et al.
patent: 5631219 (1997-05-01), Rosenthal et al.
patent: 5635538 (1997-06-01), Weers et al.
patent: 5635539 (1997-06-01), Clark, Jr. et al.
patent: 5650388 (1997-07-01), Shorr et al.
patent: 5661124 (1997-08-01), Hoffman et al.
patent: 5814601 (1998-09-01), Winslow et al.
patent: 5985825 (1999-11-01), Winslow et al.
patent: 6054427 (2000-04-01), Winslow
patent: 6432918 (2002-08-01), Winslow
patent: 0361 719 (1990-04-01), None
patent: WO87/07832 (1987-12-01), None
patent: WO90/13309 (1990-11-01), None
patent: WO91/07190 (1991-05-01), None
Guyton,Human Physiology And Mechanisms Of Disease(3rd. ed.; W.B. Saunders Co., Philadelphia, PA), pp. 228-229 (1982).
Hannon et al., “Blood and Acid-base Status of Conscious Pigs subjected to Fixed-volume Hemorrhage and Resuscitated with Hypertonic Saline Dextran,”Circulatory Shock32:19-29 (1990).
Intaglietta, “Whitaker Lecture 1996: Microcirculation, Biomedical Engineering, and Artificial Blood,”Ann. Biomed. Engineer.25:593-603 (1997).
Iwasaki and Iwashita, “Preparation and Evaluation of Hemoglobin-Polyethylene Glycol Conjugate (Pyridoxalated Polyethylene Glycol Hemoglobin) as an Oxygen-Carrying Resuscitation Fluid,”Artif. Organs10:411-416 (1986).
Kerger et al., “Systemic and subcutaneous microvascular oxygen tension in conscious Syrian golden hamsters,”Am. J. Physiol.267 (Heart. Circ. Physiol.37):H802-810 (1995).
Mirhashemi et al., “Model analysis of the enhancement of tissue oxygenation by hemodilution due to increased microvascular flow velocity,”Microvasc. Res.34:290-301 (1987).
Mirhashemi et al., “Effects of hemodilution on skin microcirculation,”Am. J. Physiol.254:H411-H416 (1988).
Papenfuss et al., “A transparent access chamber for the rat dorsal skin fold,”Microvasc. Res.18:311-318 (1979).
Prouchayret et al., “A Potential Blood Substitute from Carboxylic Dextran and Oxyhemoglobin. I. Preparation, Purification and Characterization,”Biomat. ARt. Cells&Immolb. Biotech.20: 319-322 (1992).
Reinhart et al., “Rheologic Measurements on Small Samples with a New Capillary Viscometer,”J. Lab. Clin. Med.104:921-31 (1984).
Simoni et al., “An Improved Blood Substitute,”In VivoEvaluation of its Hemodynamic Effects,ASAIO J.,42:M773-782 (1996).
Sherwood (ed.),Fundamentals of Physiology,2ndedition, West Publishing Company: St. Paul, MN, pp. 256-258 & 339-344 (1995).
Stetter et al., “Influence of a Recombinant Hemoglobin Solution on Blood Rheology,”Transfusion37:1149-1155 (1997).
Tai and Intaglietta, “Local tissue oxygenation by statistically distributed sources,”Microvasc. Res.44:200-213 (1992).
Tsai et al., “Microcirculatory consequences of blood substitution with α α -hemoglobin,” in Winslow et al., (eds).,Blood Substitutes. Physiological Basis of Efficacy,Birkhäuser, Boston, MA, pp. 155-174 (1995).
Vandegriff and Shrager, “Hemoglobin-Oxygen Equilibrium Binding: Rapid-Scanning Spectrophotometry and Singular Value Decomposition,”Meth. Enzymol.232:460-485 (1994).
Winslow et al., “Oxygen Equilibrium Curve of Normal Human Blood and Its Evaluation by Adair's Equation,”J. Biol. Chem.252(7):2331-2337 (1977).
Medlen & Carroll LLP
Mohamed Abdel A.
The Regents of the University of California
Weber Jon
LandOfFree
Methods and compositions for optimization of oxygen... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for optimization of oxygen..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for optimization of oxygen... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3610443